Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.

Researchers are developing a variety of approaches for clearing neural tissue to get a better view of the brain’s circuitry.

Researchers describe ways to study how cancer cells evade therapies that harness the immune system.

Advances in the functional characterization of newly discovered microproteins hint at diverse roles in health and disease.

Computational biologists are optimistic that the purchase of the world’s largest hub for open-source computer code will not affect the way they use GitHub for science.

Synthetic and natural alternatives to traditional antibodies offer more control, specificity, and reproducibility. 

Software that can separate signals from noise brings neuroscientists a step closer to understanding neurons’ patterns of communication.

Researchers are using light and new image processing tools for label-free cell characterization.

Facing problems of inconsistent, time-consuming, and costly antibody production, some researchers are turning to alternatives to target specific proteins of interest, in the lab and in the clinic.

Researchers devise new techniques to facilitate growing bacteria collected from the environment.

A pioneer of the gene-editing technique discovers a protein that could improve its accuracy.

Two giants merge as the German drug maker acquires the US-based science supply company.

Integrated viral sequences can dysregulate genes.